Collaboration is essential to drive innovation in pharma and bring new medicines to patients. In this article, we discuss how close cooperation between regulatory and medical affairs helps to streamline regulatory interactions.
In this second article in our consultant Q&A series, we sat down with Sarah Hollywood, to learn about her experiences working on medical affairs projects with PharmaMedic. If you’re thinking of taking the plunge into medical or regulatory affairs consultancy, read the article for Sarah’s account of life as a PharmaMedic consultant.
In this new article, we sit down with Lucy Cook, one of the PharmaMedic Consultancy network to talk about her experience in medical affairs, work-life balance, and how PharmaMedic Consultancy helps her to do more of the technical work she enjoys without the traditional headaches of self-employment.
Now more than ever, we need to apply old-fashioned common sense to help drive advances in healthcare. In this article we discuss how reconfiguring and repurposing of medicines have come to the fore during the COVID-19 pandemic.
With the COVID-19 pandemic disrupting medical provision across the globe, healthcare providers urgently need to improve efficiency of patient care. Read our new article to learn how artificial intelligence is being used in clinical decision-making.
Like all sectors, the pharmaceutical industry is facing an unparalleled period of uncertainty. As experienced pharmaceutical consultants, we are well equipped to adapt, thrive and add value in this changing environment. In this article, we explore some of the skills and qualities that we need to embrace now more than ever.
PharmaMedic's VirtualPharma™ Solution is backed by decades of medical affairs experience and built on four key pillars. Read more to learn how we help pharma and biotech companies of all sizes with flexible solutions.
Navigating the information overload of COVID-19 is a challenge. In this short update, PharmaMedic rounds up some top resources for individuals, pharma and biotech researchers.
Outsourcing medical affairs could be your next best strategic move. Learn how in PharmaMedic’s latest blog.
Trump effect on Intellectual Property, Pricing, R&D in global trade deals.
